XenoPort Lands $20,000,000 New Financing Round

  • Feed Type
  • Date
    11/20/2012
  • Company Name
    XenoPort
  • Mailing Address
    3410 Central Expressway Santa Clara, CA 95051
  • Company Description
    XenoPort, Inc., based in Santa Clara, California, is a privately held biopharmaceutical company focused on harnessing the bodys intrinsic cellular transport systems to improve the oral absorption, distribution and pharmacokinetics of drugs.
  • Website
    http://www.xenoport.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed